Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SLC25A5P6 (solute carrier family 25 member 5 pseudogene 6, also known as ANTP6) is a human pseudogene related to the solute carrier family 25, member 5 (SLC25A5), which encodes the mitochondrial adenine nucleotide translocator 2 (ANT2)[1][3]. Unlike its functional parent gene, SLC25A5P6 does not produce a protein and is not considered an active molecular target for therapy or drug development. Pseudogenes such as SLC25A5P6 may be included in large genomic datasets and can have roles in gene regulation or as noncoding RNAs in rare cases, but there is no evidence supporting a direct biological or therapeutic role for this specific pseudogene[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 25 member 5 pseudogene 6 (SLC25A5P6).